Karyopharm Therapeutics (NASDAQ:KPTI) executives highlighted upcoming late-stage clinical catalysts, continued revenue growth ...
In the last year, multiple insiders have substantially increased their holdings of EVT Limited (ASX:EVT) stock, indicating that insiders' optimism about the company's prospects has increased. While ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results